ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
Edmorgrimm
|
181 |
62K |
4 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
181
|
62K
|
4
|
|
ASX - By Stock
|
EBR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Edmorgrimm
|
7 |
1.1K |
4 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
7
|
1.1K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
Edmorgrimm
|
181 |
62K |
7 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
181
|
62K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
Edmorgrimm
|
181 |
62K |
24 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
181
|
62K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
Edmorgrimm
|
181 |
62K |
22 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
181
|
62K
|
22
|
|
ASX - By Stock
|
DXB |
Re:
DJ Dimerix Initiated at A$0.80/Share Price Target by Euroz Hartleys
|
|
Edmorgrimm
|
11 |
4.7K |
7 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
11
|
4.7K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
Edmorgrimm
|
181 |
62K |
26 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
181
|
62K
|
26
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q1 2024 quarterly activity and cash flow report
|
|
Edmorgrimm
|
15 |
6.3K |
30 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
15
|
6.3K
|
30
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Successful Completion of Retail Entitlement Offer
|
|
Edmorgrimm
|
5 |
1.5K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
5
|
1.5K
|
7
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Edmorgrimm
|
11 |
3.1K |
22 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
11
|
3.1K
|
22
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
Edmorgrimm
|
330 |
91K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
330
|
91K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Kidney Disease Drug Candidate Progressing to Human Trials
|
|
Edmorgrimm
|
28 |
8.6K |
6 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
28
|
8.6K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
Edmorgrimm
|
48 |
13K |
7 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
48
|
13K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Kidney Disease Drug Candidate Progressing to Human Trials
|
|
Edmorgrimm
|
28 |
8.6K |
4 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
28
|
8.6K
|
4
|
|
ASX - By Stock
|
TLG |
Re:
Ann: Talga Investor Webinar
|
|
Edmorgrimm
|
5 |
3.2K |
20 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
5
|
3.2K
|
20
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
Edmorgrimm
|
48 |
13K |
13 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
48
|
13K
|
13
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Kidney Disease Drug Candidate Progressing to Human Trials
|
|
Edmorgrimm
|
28 |
8.6K |
16 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
28
|
8.6K
|
16
|
|
ASX - By Stock
|
WA8 |
Re:
The Warriedar story just keeps getting better.
|
|
Edmorgrimm
|
49 |
10K |
2 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
49
|
10K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Edmorgrimm
|
2.4K |
1.1M |
15 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Edmorgrimm
|
9.9K |
4.4M |
24 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
24
|
|
ASX - By Stock
|
WA8 |
Re:
The Warriedar story just keeps getting better.
|
|
Edmorgrimm
|
49 |
10K |
12 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
49
|
10K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Edmorgrimm
|
9.9K |
4.4M |
32 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
32
|
|
ASX - By Stock
|
WA8 |
Re:
Ann: ********* Hidden Gems Webinar Presentation
|
|
Edmorgrimm
|
9 |
1.9K |
7 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
9
|
1.9K
|
7
|
|
ASX - By Stock
|
WA8 |
Re:
Ann: ********* Hidden Gems Webinar Presentation
|
|
Edmorgrimm
|
9 |
1.9K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
9
|
1.9K
|
2
|
|
ASX - By Stock
|
TLG |
Re:
TLG - Media
|
|
Edmorgrimm
|
15K |
4.9M |
20 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
15K
|
4.9M
|
20
|
|
ASX - By Stock
|
EBR |
Re:
General Investor Information EBR Systems
|
|
Edmorgrimm
|
248 |
79K |
6 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
248
|
79K
|
6
|
|
ASX - By Stock
|
SPR |
Re:
Ann: A$80m Fully Underwritten Equity Raising to Accelerate Explor
|
|
Edmorgrimm
|
157 |
47K |
4 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
157
|
47K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity launches $121 million equity raise
|
|
Edmorgrimm
|
87 |
30K |
7 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
87
|
30K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity launches $121 million equity raise
|
|
Edmorgrimm
|
87 |
30K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
87
|
30K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Edmorgrimm
|
9.9K |
4.4M |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Edmorgrimm
|
9.9K |
4.4M |
40 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
40
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Edmorgrimm
|
2.4K |
1.1M |
14 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Edmorgrimm
|
9.9K |
4.4M |
22 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
22
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Edmorgrimm
|
255 |
110K |
2 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
255
|
110K
|
2
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Edmorgrimm
|
106 |
43K |
4 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
106
|
43K
|
4
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Edmorgrimm
|
106 |
43K |
5 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
106
|
43K
|
5
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Edmorgrimm
|
106 |
43K |
1 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
106
|
43K
|
1
|
|
ASX - By Stock
|
TLG |
Re:
TLG Chart
|
|
Edmorgrimm
|
3.6K |
1.3M |
2 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
3.6K
|
1.3M
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
Edmorgrimm
|
626 |
198K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
626
|
198K
|
1
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Edmorgrimm
|
106 |
43K |
3 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
106
|
43K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Chart Thread
|
|
Edmorgrimm
|
160 |
47K |
6 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
160
|
47K
|
6
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Edmorgrimm
|
106 |
43K |
7 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
106
|
43K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Edmorgrimm
|
9.9K |
4.4M |
13 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
13
|
|
ASX - By Stock
|
PYC |
Re:
Ann: $74.6 Million Extension of Cash Runway
|
|
Edmorgrimm
|
15 |
4.8K |
5 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
15
|
4.8K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
Ann: $74.6 Million Extension of Cash Runway
|
|
Edmorgrimm
|
15 |
4.8K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
15
|
4.8K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Ann: $74.6 Million Extension of Cash Runway
|
|
Edmorgrimm
|
15 |
4.8K |
14 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
15
|
4.8K
|
14
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
Edmorgrimm
|
806 |
275K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
806
|
275K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Edmorgrimm
|
2.6K |
640K |
15 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
2.6K
|
640K
|
15
|
|
ASX - By Stock
|
TLG |
Re:
Ann: Becoming a substantial holder
|
|
Edmorgrimm
|
8 |
3.6K |
1 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
8
|
3.6K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Edmorgrimm
|
255 |
110K |
10 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
255
|
110K
|
10
|
|